Citation Impact
Citing Papers
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
2003 StandoutScience
Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
2010
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
2009 Standout
Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide
2002
Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
2003
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Reinduction of ErbB2 in astrocytes promotes radial glial progenitor identity in adult cerebral cortex
2007
Ras Inhibition in Glioblastoma Down-regulates Hypoxia-Inducible Factor-1α, Causing Glycolysis Shutdown and Cell Death
2005
Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas
2007
Boron Neutron-Capture Therapy (BNCT) for Glioblastoma Multiforme (GBM) Using the Epithermal Neutron Beam at the Brookhaven National Laboratory
1998
IDH1andIDH2Mutations in Gliomas
2009 Standout
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study.
1998
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells
2004
The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly
1995
Phase 2 study of weekly irinotecan in adults with recurrent malignantglioma: Final report of NABTT 97-11
2004
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
2001
Clinical trial participation among patients enrolled in the Glioma Outcomes Project
2002
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma
2003
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma
2012
Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating Agents
2000 Standout
Pharmacology of imatinib (STI571)
2002
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma
2005
Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: growth factor and Ras signaling pathways
2003
Cancer immunotherapy via dendritic cells
2012 Standout
High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours
2000
Factors influencing survival in high-grade gliomas
2003
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
1994
Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4
2007
Signals controlling the expression of PDGF
1996
Genetic modeling of gliomas in mice: New tools to tackle old problems
2011
The Molecular and Genetic Basis of Neurological Tumours
2002
Participation in Cancer Clinical Trials
2004 Standout
Gliomagenesis: genetic alterations and mouse models
2001
p21 in cancer: intricate networks and multiple activities
2009 Standout
Angiogenesis in life, disease and medicine
2005 StandoutNature
Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics
1997
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Structural and functional specificities of PDGF‐C and PDGF‐D, the novel members of the platelet‐derived growth factors family
2005
Malignant glioma: Who benefits from adjuvant chemotherapy?
1998
Enhancing Radiotherapy by Lipid Nanocapsule-Mediated Delivery of Amphiphilic Gold Nanoparticles to Intracellular Membranes
2014
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
Malignant Gliomas in Adults
2008 Standout
Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial
2006
Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme
2006
Inhibiting kinases in malignant gliomas
2007
Sickle-cell disease
2010 Standout
Polymeric controlled-release amsacrine chemotherapy in an experimental glioma model
1996
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Glioma Stem Cells: A Midterm Exam
2008
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Somatic cell type specific gene transfer reveals a tumor-promoting function for p21Waf1/Cip1
2007
Role of KIT and platelet-derived growth factor receptors as oncoproteins
2004
Primary brain tumours in adults
2012 Standout
Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas
2005
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Identification of human brain tumour initiating cells
2004 StandoutNature
Platelet-Derived Growth Factor-BB Controls Epithelial Tumor Phenotype by Differential Growth Factor Regulation in Stromal Cells
2006
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data
2010
Radiation Therapy-Induced Tumor Invasiveness Is Associated with SDF-1-Regulated Macrophage Mobilization and Vasculogenesis
2013
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
2009
A restricted cell population propagates glioblastoma growth after chemotherapy
2012 StandoutNature
Platelet-derived growth factor plays a critical role to convert bone marrow cells into glomerular mesangial-like cells
2003 StandoutNobel
Brain Tumors
2001 Standout
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
PDGFRα-Positive B Cells Are Neural Stem Cells in the Adult SVZ that Form Glioma-like Growths in Response to Increased PDGF Signaling
2006
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
2005 Standout
Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials
1999
Bis(1H-2-indolyl)methanones as a Novel Class of Inhibitors of the Platelet-Derived Growth Factor Receptor Kinase
2002
Expression of platelet derived growth factor and platelet derived growth factor receptor mRNA in a glioblastoma from a patient with Li-Fraumeni syndrome.
1995
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
2008 StandoutNobel
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study
2008
Polymeric Systems for Controlled Drug Release
1999 Standout
Food and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
2005
A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival
2005
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.
2001
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme
2005
Comparison of Stereotactic Radiosurgery and Brachytherapy in the Treatment of Recurrent Glioblastoma Multiforme
1995
Platelet-derived Growth Factor and Its Receptor Expression in Human Oligodendrogliomas
1998
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials
2002
Radiosurgery for malignant meningioma: results in 22 patients
2000 StandoutNobel
Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia.
2002
Concepts in Ras-directed therapy
1999
Phase III Study Comparing Three Cycles of Infusional Carmustine and Cisplatin Followed by Radiation Therapy With Radiation Therapy and Concurrent Carmustine in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme: Eastern Cooperative Oncology Group Trial 2394
2003
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
2008 Standout
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.
2000
Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors
1999
Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
2002
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas
2003
Which glioblastoma multiforme patient will become a long-term survivor? A population-based study
1999
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death.
2005
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase.
2002
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Works of Peter Black being referenced
Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
1993
Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop
1995